These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Towards a harmonized radiopharmaceutical regulatory framework in Europe? Decristoforo A; Peñuelas I Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):394-401. PubMed ID: 19834449 [TBL] [Abstract][Full Text] [Related]
24. Establishment of a national program for quality control of nuclear medicine instrumentation. Coca Perez MA; Torres Aroche LA; Bejerano GL; Mayor RF; Corona CV; López A J Nucl Med Technol; 2008 Dec; 36(4):203-6. PubMed ID: 19008290 [TBL] [Abstract][Full Text] [Related]
25. The good laboratory practice and good clinical practice requirements for the production of radiopharmaceuticals in clinical research. De Vos FJ; De Decker M; Dierckx RA Nucl Med Commun; 2005 Jul; 26(7):575-9. PubMed ID: 15942476 [TBL] [Abstract][Full Text] [Related]
26. [Nuclear medicine entangled by administrative regulations]. Meyer GJ Nuklearmedizin; 2013; 52(2):N11-5. PubMed ID: 23503760 [TBL] [Abstract][Full Text] [Related]
27. Workplace monitoring for exposures to radon and to other natural sources in Europe: integration of monitoring for internal and external exposures. Lopez MA; Currivan L; Falk R; Olko P; Wernli C; Castellani CM Radiat Prot Dosimetry; 2004; 112(1):121-39. PubMed ID: 15574988 [TBL] [Abstract][Full Text] [Related]
28. Harmonisation of individual monitoring in Europe. Schumacher H; Phihet P Radiat Prot Dosimetry; 2004; 112(1):1-2. PubMed ID: 15574984 [No Abstract] [Full Text] [Related]
29. Comprehensive Auditing in Nuclear Medicine Through the International Atomic Energy Agency Quality Management Audits in Nuclear Medicine (QUANUM) Program. Part 1: the QUANUM Program and Methodology. Dondi M; Torres L; Marengo M; Massardo T; Mishani E; Van Zyl Ellmann A; Solanki K; Bischof Delaloye A; Lobato EE; Miller RN; Paez D; Pascual T Semin Nucl Med; 2017 Nov; 47(6):680-686. PubMed ID: 28969766 [TBL] [Abstract][Full Text] [Related]
30. Radiation exposure from diagnostic nuclear medicine in Alagoas (Brazil) in 2002-2005. Yano VF; Lima FF Cell Mol Biol (Noisy-le-grand); 2010 May; 56(2):25-30. PubMed ID: 20525455 [TBL] [Abstract][Full Text] [Related]
32. [Guidelines for radiation protection in medicine--radiopharmaceutical quality control. German Society of Nuclear Medicine]. Brandau W Nuklearmedizin; 1994 Apr; 33(2):118-24. PubMed ID: 8177754 [TBL] [Abstract][Full Text] [Related]
33. [German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging]. Barthel H; Meyer PT; Drzezga A; Bartenstein P; Boecker H; Brust P; Buchert R; Coenen HH; la Fougère C; Gründer G; Grünwald F; Krause BJ; Kuwert T; Schreckenberger M; Tatsch K; Langen KJ; Sabri O Nuklearmedizin; 2016 Aug; 55(4):129-37. PubMed ID: 27080914 [TBL] [Abstract][Full Text] [Related]
34. [Nuclear medicine 2001 and "Guidelines for use of radioactivity in medicine": consequences for nuclear medicine]. Reiners C; Schicha H Nuklearmedizin; 2002; 41(4):168-70. PubMed ID: 12224399 [No Abstract] [Full Text] [Related]
35. Radiation doses for pediatric nuclear medicine studies: comparing the North American consensus guidelines and the pediatric dosage card of the European Association of Nuclear Medicine. Grant FD; Gelfand MJ; Drubach LA; Treves ST; Fahey FH Pediatr Radiol; 2015 Apr; 45(5):706-13. PubMed ID: 25367355 [TBL] [Abstract][Full Text] [Related]
36. A return to basics, a focus on the future. Shaw LJ; Bateman TM; Heller GV; Lewin HC; Flood KB J Nucl Cardiol; 2011 Dec; 18(6):1116-7. PubMed ID: 22068686 [No Abstract] [Full Text] [Related]
37. Nuclear medicine in Europe. Considerations of present status and future trends. Pretschner DP Eur J Nucl Med; 1980 Apr; 5(2):175-84. PubMed ID: 6103807 [TBL] [Abstract][Full Text] [Related]
38. Nuclear cardiology practice and associated radiation doses in Europe: results of the IAEA Nuclear Cardiology Protocols Study (INCAPS) for the 27 European countries. Lindner O; Pascual TN; Mercuri M; Acampa W; Burchert W; Flotats A; Kaufmann PA; Kitsiou A; Knuuti J; Underwood SR; Vitola JV; Mahmarian JJ; Karthikeyan G; Better N; Rehani MM; Kashyap R; Dondi M; Paez D; Einstein AJ; Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):718-28. PubMed ID: 26686336 [TBL] [Abstract][Full Text] [Related]
39. Quality assurance of nuclear medicine instrumentation. Paras P Ric Clin Lab; 1981; 11(4):357-77. PubMed ID: 7323614 [TBL] [Abstract][Full Text] [Related]
40. European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands. Tatsch K; Asenbaum S; Bartenstein P; Catafau A; Halldin C; Pilowsky LS; Pupi A; Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):BP30-5. PubMed ID: 12436496 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]